| 000 | 01876 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516232942.0 | ||
| 264 | 0 | _c20150210 | |
| 008 | 201502s 0 0 eng d | ||
| 022 | _a1098-5514 | ||
| 024 | 7 |
_a10.1128/JVI.01532-14 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKamlangdee, Attapon | |
| 245 | 0 | 0 |
_aBroad protection against avian influenza virus by using a modified vaccinia Ankara virus expressing a mosaic hemagglutinin gene. _h[electronic resource] |
| 260 |
_bJournal of virology _cNov 2014 |
||
| 300 |
_a13300-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Neutralizing _xblood |
| 650 | 0 | 4 |
_aAntibodies, Viral _xblood |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aCross Protection |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDrug Carriers _xadministration & dosage |
| 650 | 0 | 4 | _aGenetic Vectors |
| 650 | 0 | 4 |
_aHemagglutinin Glycoproteins, Influenza Virus _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfluenza A Virus, H1N1 Subtype _ximmunology |
| 650 | 0 | 4 |
_aInfluenza A Virus, H5N1 Subtype _xgenetics |
| 650 | 0 | 4 |
_aInfluenza Vaccines _xadministration & dosage |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aOrthomyxoviridae Infections _xprevention & control |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xgenetics |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aVaccination _xmethods |
| 650 | 0 | 4 |
_aVaccines, Synthetic _xadministration & dosage |
| 650 | 0 | 4 |
_aVaccinia virus _xgenetics |
| 700 | 1 | _aKingstad-Bakke, Brock | |
| 700 | 1 | _aAnderson, Tavis K | |
| 700 | 1 | _aGoldberg, Tony L | |
| 700 | 1 | _aOsorio, Jorge E | |
| 773 | 0 |
_tJournal of virology _gvol. 88 _gno. 22 _gp. 13300-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/JVI.01532-14 _zAvailable from publisher's website |
| 999 |
_c24180112 _d24180112 |
||